SCHEMBL1001541

SCHEMBL1001541

CCCC(Br)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3795539 0.96 TSHR (0.33)
SCHEMBL19638422 0.96
SCHEMBL597312 0.87
SCHEMBL10482561 0.87
SCHEMBL574546 0.85
SCHEMBL24634076 0.84
SCHEMBL5988860 0.84
SCHEMBL233991 0.84
SCHEMBL19784242 0.84 TSHR (0.33)
SCHEMBL8714312 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109173756-B Bromine alkyl quaternized polypyrrole modified cation exchange membrane and preparation and application thereof 浙江工业大学 2020-10-27 CN claimed
CN-109173756-A A kind of quaternized polypyrrole modified cation exchange membrane of bromine alkane and its preparation and application 浙江工业大学 2019-01-11 CN claimed
US-20250282736-A1 SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR ST JUDE CHILDRENS RES HOSPITAL (US) 2025-09-11 US disclosed
US-12029708-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2024-07-09 US disclosed
US-20240210382-A1 METHODS, DATABASE AND SYSTEM FOR USE WITH VIRAL INFECTION RESPIRATION SCAN LTD. (IL) 2024-06-27 US disclosed
WO-2023205344-A1 SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2023-10-26 WO disclosed
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed
CN-115433195-A Alkyl substituted narcotine derivative and preparation method and application thereof 华东理工大学 2022-12-06 CN disclosed
US-11446261-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2022-09-20 US disclosed
CN-110066278-B Fused tricyclic compound and application thereof in medicines 广东东阳光药业有限公司 2021-06-08 CN disclosed
US-10966970-B2 Fused tricyclic compounds and uses thereof in medicine SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-04-06 US disclosed
US-5693396-A NEAR INFRARED LIGHT ABSORBERS MITSUI TOATSU CHEMICALS, INC. (JP) 1997-12-02 US disclosed
EP-0777471-A1 INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH UREA DERIVATIVES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-06-11 EP disclosed
US-5612377-A OXYUREA DERIVATIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-03-18 US disclosed
EP-0719839-A2 Phthalocyanine compounds and optical recording media comprising them MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-07-03 EP disclosed
WO-1996003983-A1 INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH UREA DERIVATIVES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-02-15 WO disclosed
WO-1993016996-A1 INDOLE DERIVATIVES AS TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-09-02 WO disclosed
EP-0253838-B1 CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING N-SEC-ALKYL PYRIDINIUM SALTS MALLINCKRODT SPECIALTY CHEMICALS COMPANY (US) 1991-08-21 EP disclosed
US-4973771-A Phase transfer catalysts MALLINCKRODT, INC. (US) 1990-11-27 US disclosed
WO-1987004149-A1 PHASE TRANSFER CATALYSTS MALLINCKRODT, INC. (US) 1987-07-16 WO disclosed